Navigation Links
Researchers find first conclusive evidence of Alzheimer's-like brain tangles in nonhuman primates
Date:5/14/2008

Researchers at the Yerkes National Primate Research Center, Emory University, have discovered the first conclusive evidence of Alzheimer's-like neurofibrillary brain tangles in an aged nonhuman primate. The unprecedented finding, described in the online issue of the Journal of Comparative Neurology, has the potential to move the scientific community one step closer to understanding why age-related neurodegenerative diseases, such as Alzheimer's disease, are uniquely human and seem to never fully manifest in other species--including our closest evolutionary relative, the chimpanzee.

Lead researchers Rebecca Rosen, a doctoral student who is conducting her research at Yerkes, and Lary Walker, PhD, a neuroscientist and research professor at Yerkes, in collaboration with colleagues at UCLA, made the unanticipated finding during a routine post-mortem study of an aged, female chimpanzee that died of natural causes. The researchers also discovered deposits of beta-amyloid protein in plaques and blood vessels of the chimp's brain tissue, although these changes were infrequent compared to Alzheimer's disease in humans.

"We've seen these plaques in aged chimpanzees before, but this is the first time researchers have found both hallmark features of Alzheimer's disease--plaques and neurofibrillary tangles--in a nonhuman primate," explains Walker.

As many as five million Americans are living with Alzheimer's disease, the most common form of dementia. A cure has eluded researchers, and the disease is considered progressive and fatal. Brain plaques and tangles associated with the disease are prime suspects in damaging and killing nerve cells that cause memory loss and dementia.

"Alzheimer's disease has a huge number of potential causes," says Rosen. "By studying the development of human features of the disease that occur naturally in nonhuman primates, we may be able to isolate what makes people so susceptible to neurodegenerative disease
'/>"/>

Contact: Emily Rios
erios@emory.edu
404-727-7732
Emory University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Vancouver researchers discover missing link between TB bacteria and humans
2. 1 of the best researchers in general practice
3. Researchers fine-tune clot-busting treatment for bleeding in brain
4. OHSU Cancer Institute researchers pinpoint how smoking causes cancer
5. Yerkes researchers find link between psychological stress and overeating
6. Researchers who helped millions with arthritis receive prestigious Janssen Award
7. Carnegie Mellon engineering researchers automate analysis of protein patterns
8. Health researchers in McGill network receive $35.5 million in CIHR funding
9. Hopkins researchers discover new link to schizophrenia
10. Researchers find gene location that gives rise to neuroblastoma, an aggressive childhood cancer
11. Researchers Find Gene Location That Gives Rise to Neuroblastoma, an Aggressive Childhood Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...in younger women may up chances of disease, study ...s) -- Mammograms may actually boost the risk of br...uggests. , Dutch researchers analyzed six previ... of low-dose radiation exposure from mammography a...st cancer risk and two looking at the effect of ra...
(Date:12/1/2009)... Pilots will enable local organizations to te...r for consumers who lack access , ...en Fund, a nonprofit venture firm addressing pover...t has selected four organizations in Kenya to cond... transportation and storage. , , ,The pilot progra...
(Date:12/1/2009)..., IRVINE, Calif., Dec. 1 ...CO-Oximetry(TM) and Measure-Through Motion and Low...arance of its latest innovation -- Masimo Rainbow ...sive and continuous respiration rate (RRa(TM)) tha...ompliance. Masimo Rainbow SET Acoustic Monitoring...
(Date:12/1/2009)... Free hearing aids will be given by Estes Aud... Austin, TX (PRWEB) December...m ), a professional hearing healthcare provider de...ired and their families, announced today the begin...giveaway. Each year, Estes Audiology donates two ...
(Date:12/1/2009)... All Federal and Georgia State Retirees who a.... This new benefit is part of the Medicare Advanta...fee for service (PFFS) Options offered by CIGNA, B...r Permanente. Atlanta Hearing Associates has three... Oconee / Greensboro, GA and Lake Sinclair / Mille...
Breaking Medicine News(10 mins):Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 3Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 3Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 4
...to offer good news for older adults .The first stu... depression // in the elderly. Researchers studied...participants suffered from major depression, while...study show seniors who received the home-based pro...
...ng pneumonia may mean just a short-term lease on a...lts of the study show // increasing age combined w...e, an altered mental state, and anemia were signif...olled diabetes and a hematocrit (ratio of the volu...
...tion after heart surgery may not be the be the wis...archers.// A recent study confirms that corona...heart medications, such as beta blockers and ACE i...edication. However, this assumption was questioned...
...e conditions such as chronic bronchitis and emphys... // and gradual loss of lung function that cannot ...use of death in the United States. A test known...pirometry test and a screening questionnaire to de...
...tendon near a joint becomes inflamed. Treatment is... a new approach relieves the pain of this common c... with tendonitis are finding relief with extracorp...ave treatments to relieve the pain of chronic tend...
...dy researchers say zinc supplements may increase t...ttention deficit hyperactivity // disorder ( ADHD ...n of melatonin, which helps regulate dopamine func... of reward and pleasure. Zinc is a mineral tha...
Other Medicine News:
(Date:11/30/2009)...C., Nov. 30 Microban International...l product protection, is pleased to announce their... Corp., the largest U.S. manufacturer and distribu...orp is launching two new lines of ceramic tile wit...;) patent pending silver based technology, in orde...
(Date:11/30/2009)...PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI... technique for the detection of ductal carcinoma i...er. BSGI is a molecular breast imaging technique t...and discover very early stage cancers. According t...f the Radiological Society of North America (RSNA)...
(Date:11/30/2009)..., Nov. 30 SCOLR Pharma, ...vember 25, 2009, the NYSE Amex LLC (the "Exchange"...mpany,s plan to comply with its previously disclos... the Exchange Company Guide. Specifically, the de...losses which were so substantial in relation to it...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4University of Louisville neuroscientists hope to get people walking again 58667 1Experts gather at McGill University to address food security challenges 10216 1EPA reviews Univ of Michigan dioxin study 10212 1EPA reviews Univ of Michigan dioxin study 10212 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
.../See™ is a 1-step, hand-held, point-of-care ...ug metabolites in human urine. The TOX/See device... drugs in 3 to 8 minutes and requires only a few d...ly packaged to maximize convenience and ease of us...
ESR-10 Manual Rack
...eck Cytometry Concentrate is for use as a sheath f...ach 70ml bottle of Cytometry Concentrate dilutes t...d to Cubitainers, Streck Cytometry Concentrate red...es money without compromising performance. Streck ...
CD-Chex CD34 Leukocyte Control
Medicine Products: